Table 2 Neurological outcomes
Primary Tx | Patients total (n) | 1st presentation n (%) | Neurological progressive disease n (%) | Further Neuro tx n (%) | Neuro death n (%) | Median overall survival (months) | ||
|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Local | New mets | Both | Â | Â | Â |
Surgery alone | 59 | 18 (30.5) | 12 (20.3) | 4 (6.8) | 11 (18.6) | 29 (49.2) | 18 (30.5) | 12 (1–79) |
Surgery + WBRT | 10 | 6 (60) | 4 (40) | 1 (10) | 1 (10) | 4 (40) | 2 (20) | 16 (8–46) |
RS | 16 | 1 (6.3) | 2 (12.5) | 3 (18.8) | 1 (6.3) | 6 (37.5) | 5 (31.3) | 13 (2–62) |
WBRT * | 23 | 3 (13.0) | 7 (30.4) | 5 (21.7) | 3 (13.0) | 10 (43.5) | 9 (39.1) | 23 (3–46) |
Any | 114 | 29 (25.4) | 29 (25.4) | 13 (11.4) | 17 (14.9) | 50 (43.9) | 37 (32.5) | 16 (1–79) |